Home/Filings/4/0001053310-12-000001
4//SEC Filing

KAY E GERALD 4

Accession 0001053310-12-000001

CIK 0001016504other

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 6:32 PM ET

Size

5.1 KB

Accession

0001053310-12-000001

Insider Transaction Report

Form 4
Period: 2012-06-27
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
  • Sale

    COMMON STOCK

    2012-06-27$0.09/sh250,000$22,5005,270,444 total
Footnotes (2)
  • [F1]Shares disposed of in connection with a refinancing transaction involving the issuer. The Reporting Person has no preset intent to dispose of additional shares.
  • [F2]Includes (i) 819,629 shares of common stock held by EGK LLC, of which the Reporting Person is the manager; and (ii) 307,888 shares of common stock issuable upon exercise of presently exercisable stock options; the Reporting Person shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Sheppard with respect to 169,358 shares of common stock.

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1
  • filerCIK 0001053310

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 6:32 PM ET
Size
5.1 KB